fb102
fb102: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Forte Biosciences, Inc. (FBRX) | Phase 2 |
Clinical Trials (1)
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of FB102 in Adult Participants With Celiac Disease on a Gluten Free Diet
Frequently asked questions
Who is developing fb102?
fb102 is being developed by Forte Biosciences, Inc..
How many clinical trials involve fb102?
BioSniper tracks 1 clinical trial involving fb102.
Get deeper analysis on fb102
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis